The 1961 Convention has entrusted the Board and governments to maintain a balance between supply and demand. The Board indicates that availability should be ensured for medical and scientific purposes to avoid severe pain. However, there are large disparities among the countries. There is lack of training to health professionals and legislative barriers preventing accessibility. Like the EU, we thank the Board for having such a section. We also want to remind member states to report to the INCB on availability, diversion, trafficking and abuse. If they cannot meet their requirements, they can seek the support of the INCB.
The INCB notes that increased availability of narcotic drugs may increase the diversion of abuse of these drugs, including increases in pharmaceutical drug abuse. The USA agrees that it is a key challenge in its country. One possible approach in reducing this is to educate healthcare professionals on prescription, and educate users on the dangers of such use.